General practitioners’ use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study
暂无分享,去创建一个
P. Glasziou | L. Irwig | A. Hayen | A. Teixeira-Pinto | C. Bonner | J. Jansen | K. McCaffery | J. Doust | Shannon McKinn | Robin M Turner | Robin M. Turner
[1] Jennifer G. Robinson,et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[2] Jbs Board. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) , 2014, Heart.
[3] N. Wong. Faculty Opinions recommendation of 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014 .
[4] H. Krumholz. Target cardiovascular risk rather than cholesterol concentration , 2013, BMJ.
[5] Kirsten McCaffery,et al. General practitioners’ use of different cardiovascular risk assessment strategies: a qualitative study , 2013, The Medical journal of Australia.
[6] Ž. Reiner. Polypill is not a ‘vaccine-like’ solution for primary cardiovascular disease prevention in all parts of the world , 2013, Journal of Epidemiology & Community Health.
[7] T. Marshall,et al. Patient Factors Influencing the Prescribing of Lipid Lowering Drugs for Primary Prevention of Cardiovascular Disease in UK General Practice: A National Retrospective Cohort Study , 2013, PloS one.
[8] G. Elwyn,et al. How can clinical practice guidelines be adapted to facilitate shared decision making? A qualitative key-informant study , 2013, BMJ quality & safety.
[9] E. S. Ng,et al. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment? , 2013, Heart.
[10] G. M. Allan,et al. Agreement Among Cardiovascular Disease Risk Calculators , 2013, Circulation.
[11] Ananda Sen,et al. A national survey of the treatment of hyperlipidemia in primary prevention. , 2013, JAMA internal medicine.
[12] D. Kerr,et al. Building healthy bones throughout life: an evidence‐informed strategy to prevent osteoporosis in Australia , 2013 .
[13] Shah Ebrahim,et al. [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)]. , 2013, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[14] P. Gill,et al. The Effect of Chance Variability in Blood Pressure Readings on the Decision Making of General Practitioners: An Internet-Based Case Vignette Study , 2012, PloS one.
[15] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[16] John P A Ioannidis,et al. Comparisons of established risk prediction models for cardiovascular disease: systematic review , 2012, BMJ : British Medical Journal.
[17] T. Marshall,et al. Patient and Other Factors Influencing the Prescribing of Cardiovascular Prevention Therapy in the General Practice Setting With and Without Nurse Assessment , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] J. Shaw,et al. Guidelines for the management of absolute cardiovascular disease risk , 2012 .
[19] P. Kolh,et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, European heart journal.
[20] Ž. Reiner,et al. Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey. , 2010, Atherosclerosis.
[21] J. Jukema,et al. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. , 2010, QJM : monthly journal of the Association of Physicians.
[22] A. Cass,et al. Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study) , 2010, The Medical journal of Australia.
[23] Ersen B. Colkesen,et al. Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? , 2010, Archives of internal medicine.
[24] N. Kerse,et al. Perspectives of general practitioners towards evaluation and treatment of cardiovascular diseases among older people. , 2009, Journal of primary health care.
[25] A. Cass,et al. Gaps in cardiovascular disease risk management in Australian general practice , 2009, The Medical journal of Australia.
[26] M. Neaverson. How do the Australian guidelines for lipid‐lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999–2000 , 2009, The Medical journal of Australia.
[27] P. Wilson,et al. Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions. , 2009, Current medical research and opinion.
[28] J. Shaw,et al. How do the Australian guidelines for lipid‐lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999–2000 , 2008, Medical Journal of Australia.
[29] Stacey L Sheridan,et al. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature , 2008, BMC health services research.
[30] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[31] Murray Stewart,et al. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[32] M. Moser. Historical Perspectives on the Management of Hypertension , 2006, Journal of clinical hypertension.
[33] A. Tonkin,et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005. , 2005 .
[34] M. Harris,et al. GPs' views of absolute cardiovascular risk and its role in primary prevention. , 2005, Australian family physician.
[35] Rod Jackson,et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk , 2005, The Lancet.
[36] Trudy van der Weijden,et al. Barriers to implementing cardiovascular risk tables in routine general practice , 2004, Scandinavian journal of primary health care.
[37] N J Wald,et al. A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.
[38] J W Peabody,et al. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. , 2000, JAMA.
[39] J. Larosa,et al. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. , 1999, JAMA.